Jw (Cayman) Therapeutics

(OTC) JWCTF

Current Price$0.24

Market Cap$96.40M

Since IPO (2021)-92%

5 YearN/A

1 Year-5%

1 Month-15%

Jw (Cayman) Therapeutics Financials at a Glance

Market Cap

$96.40M

Revenue (TTM)

CN¥438.93M

Net Income (TTM)

-CN¥1.14B

EPS (TTM)

-$0.19

P/E Ratio

-1.26

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$0.24

Volume

300

Open

$0.24

Price

$0.24

Volume

300

Open

$0.24

Previous Close

$0.24

Daily Range

$0.24 - $0.24

52-Week Range

$0.24 - $0.66

Estimated Earnings Date

Sep 1, 2026

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$0.24

Volume

300

Open

$0.24

Previous Close

$0.24

Daily Range

$0.24 - $0.24

52-Week Range

$0.24 - $0.66

Estimated Earnings Date

Sep 1, 2026

JWCTF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Jw (Cayman) Therapeutics

Industry

Biotechnology

Sector

Health Care

Employees

314

CEO

Feng Tian

Website

www.jwtherapeutics.com

Headquarters

Shanghai, CN

JWCTF Financials

Key Financial Metrics (TTM)

Gross Margin

43%

Operating Margin

-1%

Net Income Margin

-2%

Return on Equity

-64%

Return on Capital

-50%

Return on Assets

-56%

Earnings Yield

-79.37%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$96.40M

Shares Outstanding

405.89M

Volume

300

Avg. Volume

5.91K

Financials (TTM)

Gross Profit

CN¥118.92M

Operating Income

-CN¥241.73M

EBITDA

-CN¥161.97M

Operating Cash Flow

-CN¥76.85M

Capital Expenditure

-CN¥1.62M

Free Cash Flow

-CN¥78.46M

Cash & ST Invst.

CN¥503.32M

Total Debt

CN¥262.69M

Jw (Cayman) Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

CN¥174.36M

+102.5%

Gross Profit

CN¥56.00M

+29.0%

Gross Margin

32.12%

N/A

Market Cap

$96.40M

N/A

Market Cap/Employee

$343.06K

N/A

Employees

281

N/A

Net Income

-CN¥283.24M

+26.9%

EBITDA

-CN¥138.52M

+38.6%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Total Cash

CN¥503.32M

-50.2%

Total Debt

CN¥262.69M

-17.6%

Accounts Receivable

CN¥0.00

N/A

Inventory

CN¥62.03M

+78.4%

Long Term Debt

CN¥36.26M

-81.7%

Short Term Debt

CN¥226.32M

+87.0%

Return on Assets

-55.76%

N/A

Return on Invested Capital

-49.96%

N/A

Free Cash Flow

-CN¥78.46M

+52.7%

Operating Cash Flow

-CN¥76.85M

+52.1%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

NDTPNDT Pharmaceuticals Inc.

NDTPNDT Pharmaceuticals Inc.$0.53+0.00%

BXPHFBotanix Pharmaceuticals Limited

BXPHFBotanix Pharmaceuticals Limited$0.02+0.00%

IPHYFInnate Pharma S.A.

IPHYFInnate Pharma S.A.$1.65+0.00%

MLLCFMolecular Partners AG

MLLCFMolecular Partners AG$4.85+0.00%

YOURFYourWay Cannabis Brands Inc.

YOURFYourWay Cannabis Brands Inc.$0.00+0.00%

SCNLFScancell Holdings plc

SCNLFScancell Holdings plc$0.28+12.73%

SPHDFSanthera Pharmaceuticals Holding AG

SPHDFSanthera Pharmaceuticals Holding AG$23.25+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$13.98-0.06%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$38.35+0.06%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$79.93-0.06%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.45-0.03%

QQQInvesco QQQ Trust

QQQInvesco QQQ Trust$729.86-0.02%

ONDSOndas

ONDSOndas$9.21-0.03%

RXTRackspace Technology

RXTRackspace Technology$6.21+0.05%

Questions About JWCTF

What is the current price of Jw (Cayman) Therapeutics?

Jw (Cayman) Therapeutics is trading at $0.24 per share.

What is the 52-week range for Jw (Cayman) Therapeutics?

Over the past 52 weeks, Jw (Cayman) Therapeutics has traded between $0.24 and $0.66.

How much debt does Jw (Cayman) Therapeutics have?

As of the most recent reporting period, Jw (Cayman) Therapeutics reported total debt of CN¥37.57M.

How much cash does Jw (Cayman) Therapeutics have on hand?

Jw (Cayman) Therapeutics reported CN¥71.99M in cash and cash equivalents in its most recent financial results.

What is Jw (Cayman) Therapeutics’s dividend yield?

Jw (Cayman) Therapeutics does not currently have a dividend yield.

Jw (Cayman) Therapeutics

Jw (Cayman) Therapeutics Financials at a Glance

JWCTF News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Jw (Cayman) Therapeutics

JWCTF Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Jw (Cayman) Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About JWCTF

What is the current price of Jw (Cayman) Therapeutics?

What is the 52-week range for Jw (Cayman) Therapeutics?

How much debt does Jw (Cayman) Therapeutics have?

How much cash does Jw (Cayman) Therapeutics have on hand?

What is Jw (Cayman) Therapeutics’s dividend yield?

Premium Investing Services